跳至主要内容
临床试验/ACTRN12617001182381
ACTRN12617001182381已完成4 期

Treatment of alcohol dependent patients at-risk for subclinical Wernicke-Korsakoff syndrome: effect of thiamine dosage on neurological and cognitive symptoms

Prof Stephen Bowden0 个研究点目标入组 128 人开始时间: 2017年8月11日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Alcohol dependent patients presenting to Depaul House residential withdrawal unit.
  • Meet DSM-IV criteria for Alcohol dependence or alcohol abuse, as assessed with the Mini International Neuropsychiatric Interview (MINI) version 6.0.0 (Sheehan & Lecrubier, 2009).
  • Consumption of at least six standard drinks daily for a period of at least three months.

排除标准

  • Difficulties with language comprehension.
  • Significant pre-existing cognitive impairment due to a cause other than alcohol abuse or dependence.
  • Recent regular use of any non-prescription drug other than alcohol.

研究者

发起方
Prof Stephen Bowden

相似试验